Patients with ostial and bifurcation lesions, recent myocardial infarction (within 7 days of the acute event), allergy to aspirin or ticlopidine, history of bleeding diathesis or coagulopathy, history of stroke or transient ischemic attack within the past 3 months, a positive pregnancy test, or any end-stage disease that influences 6-month survival were excluded from this study.